OncoSec Medical Inc (ONCSQ)

[Kung Fu Panda]

There is no defacto about it. My understanding is that the FDA has a specific "Orphan Drug" fast track program where they speed through the approval process for only certain "promising" drugs. You have to apply to the FDA for this status. The Orphan Drug designation is highly sought after because it gives the company a leg up on every one else and it has a clear anticipated path to approval. That is why I am questioning the ongoing dialogue. I would expect this stock to be trading at a much higher value if it had this designation.

Either way I like what I see so far of this company. I just want to make sure the ambiguity in the discussion is addressed. That's all. Not bashing the stock or anything. Not real happy with the performance of the share price but that is another matter. I am hoping for good results this month too! Otherwise I wouldn't waste my time here and I would busy be trolling Sheff's board for the next hot one.